Iodinated (131I) Albumin Human

Discover the uses, mechanism, and safety profile of **Iodinated (131I) Albumin Human**. Learn about its role in diagnostic imaging for various medical cond

Iodinated (131I) Albumin Human Iodinated (131I) Albumin Human diagnostic uses (131I)Iod Humanalbumin imaging radioactive albumin diagnostic Iodine-131 human albumin diagnostic radiopharmaceuticals cerebrospinal fluid flow studies blood volume measurement pharmacology of Iodinated Albumin Human
🏷 ATC Code: V09FX01 📂 Diagnostic radiopharmaceuticals, Other diagnostic radiopharmaceuticals 🕐 Updated: Mar 14, 2026 ✓ Medical Reference

Looking to order Iodinated (131I) Albumin Human?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Iodinated (131I) Albumin Human?

Iodinated (131I) Albumin Human is a specialized pharmaceutical product used as a radioactive diagnostic agent in nuclear medicine. It consists of human serum albumin, a common protein found in blood plasma, that has been labeled with a radioactive isotope of iodine, specifically Iodine-131. This labeling allows the compound to be tracked within the body using external imaging equipment, making it invaluable for various diagnostic procedures.

The primary purpose of Iodinated (131I) Albumin Human is to help medical professionals visualize and assess physiological processes that involve albumin distribution or fluid dynamics. Because albumin is a large protein, it typically remains within the vascular space when administered intravenously. When administered intrathecally (into the spinal canal), it mixes with the cerebrospinal fluid (CSF). The radioactive tag emits gamma rays, which can be detected by a gamma camera, allowing for the creation of images that reveal how the substance moves and concentrates within specific areas of the body.

How Does it Work?

The diagnostic utility of Iodinated (131I) Albumin Human stems from two main properties: the biological behavior of human albumin and the physical characteristics of Iodine-131. Human albumin acts as a carrier, distributing throughout the body in a predictable manner depending on the route of administration. When injected intravenously, it primarily stays within the bloodstream, making it an excellent tracer for evaluating blood volume and circulation dynamics. When introduced into the cerebrospinal fluid, it follows the natural flow patterns of CSF, allowing for assessment of CSF circulation.

The Iodine-131 isotope attached to the albumin is a gamma-emitter, meaning it releases photons that can penetrate tissue and be detected by specialized cameras (gamma cameras or SPECT scanners). These detectors capture the emitted radiation and convert it into images, providing functional information about the body. The half-life of Iodine-131 is approximately 8 days, which is long enough for diagnostic studies but short enough to minimize long-term radiation exposure. The albumin itself is eventually metabolized and excreted, similar to normal human albumin, with the radioactive iodine being primarily excreted via the kidneys.

Medical Uses

Iodinated (131I) Albumin Human serves several critical diagnostic purposes, primarily in the fields of neurology and cardiology, as well as for general physiological assessments:

  • Cerebrospinal Fluid (CSF) Flow Studies

    One of the most common applications is in the evaluation of cerebrospinal fluid (CSF) dynamics. After intrathecal administration, the movement of the radiolabeled albumin through the CSF pathways can be monitored. This is crucial for diagnosing conditions like normal pressure hydrocephalus (NPH), assessing CSF leaks, or evaluating the patency of CSF shunts.

  • Blood Volume Determination

    When administered intravenously, Iodinated (131I) Albumin Human is used for precise blood volume determination. This measurement is vital in critically ill patients, those undergoing major surgery, or individuals with severe burns, where accurate assessment of blood and plasma volume can guide fluid resuscitation and improve patient outcomes.

  • Detection of Protein-Losing Enteropathy

    In some cases, it can be used to detect protein loss into the gastrointestinal tract, a condition known as protein-losing enteropathy. By tracking the labeled albumin, clinicians can identify and quantify abnormal protein leakage from the gut.

  • Cardiac Output and Circulation Studies

    Less commonly today due to newer techniques, it was historically used to evaluate cardiac output and various aspects of peripheral circulation.

Dosage

The dosage of Iodinated (131I) Albumin Human is highly individualized and depends on several factors, including the specific diagnostic procedure, the patient's age and weight, and the nuclear medicine facility's protocols. It is always administered by trained medical professionals in a controlled environment, typically in a nuclear medicine department. Doses are carefully calculated to provide sufficient diagnostic information while minimizing radiation exposure to the patient.

For intrathecal administration (e.g., CSF studies), the activity administered is generally very low, often in the range of 100-500 microcuries (µCi). For intravenous administration (e.g., blood volume studies), the dose might be slightly higher but still within millicurie (mCi) ranges, ensuring that the total radiation absorbed dose remains within acceptable limits. Patients are typically advised on pre-procedure preparation, which may include hydration, and post-procedure precautions, such as increased fluid intake to aid excretion of the radioisotope.

Side Effects

Side effects associated with Iodinated (131I) Albumin Human are generally rare and, when they occur, are usually mild. This is primarily due to the very small quantities of albumin and radioactivity administered for diagnostic purposes. Potential side effects include:

  • Allergic or Hypersensitivity Reactions: As the product contains human albumin, there is a theoretical risk of allergic reactions, ranging from mild skin rashes (urticaria) to more severe anaphylactic responses. However, such events are exceedingly rare.
  • Local Injection Site Reactions: Pain, redness, or swelling at the site of injection (intravenous or intrathecal) can occur, similar to any injection.
  • Transient Symptoms: Some patients may experience transient symptoms such as fever, chills, nausea, or headache, though these are uncommon.
  • Radiation Exposure: While the radiation dose is kept as low as reasonably achievable (ALARA principle), there is always a minimal amount of radiation exposure. The risks associated with this exposure are generally considered very low compared to the diagnostic benefits, especially with a short-lived isotope like Iodine-131.

Patients with a known history of allergy to human albumin or iodine should inform their healthcare provider before administration.

Drug Interactions

Significant drug interactions with Iodinated (131I) Albumin Human are not commonly reported, primarily because it is administered in minute quantities for diagnostic purposes and its pharmacological action is limited to serving as a tracer. The human albumin component is a natural body protein, and the radioactive iodine is present in trace amounts.

However, it is always prudent for patients to inform their healthcare provider about all medications they are taking, including over-the-counter drugs, supplements, and herbal remedies. While direct pharmacological interactions are unlikely, certain medications or medical conditions might indirectly affect the physiological processes being measured (e.g., drugs altering blood volume, CSF production, or protein metabolism), potentially influencing the interpretation of the diagnostic study results. For instance, drugs that impact renal function could theoretically alter the excretion rate of the radioisotope.

FAQ

Is Iodinated (131I) Albumin Human safe?

Yes, when administered by qualified personnel in appropriate diagnostic doses, it is considered safe. The radiation exposure is minimal and carefully controlled to outweigh the diagnostic benefits.

What is the role of Iodine-131?

Iodine-131 is the radioactive component that emits gamma rays, allowing the albumin to be detected by a gamma camera for imaging purposes. It has a suitable half-life for diagnostic studies.

How is it administered?

It can be administered intravenously (into a vein) for blood volume and circulation studies, or intrathecally (into the spinal canal) for cerebrospinal fluid flow studies.

Who administers this diagnostic agent?

Administration is performed by highly trained medical professionals, typically nuclear medicine physicians or technicians, in specialized hospital departments.

How long does the radioactivity stay in the body?

The radioactivity from Iodine-131 diminishes over time due to its half-life of approximately 8 days and is also gradually excreted from the body, primarily through urine.

Products containing Iodinated (131I) Albumin Human are available through trusted online pharmacies. You can browse Iodinated (131I) Albumin Human-based medications at ShipperVIP or Medicenter.

Summary

Iodinated (131I) Albumin Human is a vital diagnostic radiopharmaceutical employed in nuclear medicine imaging. By labeling human albumin with the gamma-emitting isotope Iodine-131, medical professionals can non-invasively assess critical physiological processes, including cerebrospinal fluid (CSF) dynamics and blood volume determination. Its precise applications in diagnosing conditions like normal pressure hydrocephalus, CSF leaks, and guiding fluid management underscore its importance. Administered in carefully controlled, minimal doses by specialists, it offers a safe and effective means to obtain essential diagnostic information, significantly contributing to patient care and management.